SCHEMBL20249886

SCHEMBL20249886

O=P(c1ccccc1)(c1ccc2c(c1)-c1cc(F)ccc1C2(c1ccccc1)c1ccccc1)c1ccc2c(c1)-c1cc(F)ccc1C2(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.37
LMNA P02545 2/20 0.33
PTPN1 P18031 1/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
KDM4E B2RXH2 2/20 0.33
MAPT P10636 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
OPRK1 P41145 1/20 0.33
PARK7 Q99497 1/20 0.32
KCNN4 O15554 1/20 0.32
KCNA5 P22460 1/20 0.32
LRRK2 Q5S007 1/20 0.32
TOP1 P11387 1/20 0.31
PPARG P37231 3/20 0.31
PTGS1 P23219 1/20 0.31
KIF11 P52732 1/20 0.31
RAB9A P51151 1/20 0.30
CYP19A1 P11511 1/20 0.30
BACE1 P56817 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11991104 0.91 LMNA (0.39) LMNAMEN1KMT2AKDM4EMAPT
SCHEMBL20249892 0.89 PDK2 (0.47) PDK2LMNAPTPN1MEN1KMT2A
SCHEMBL20249883 0.86 PDK2 (0.35) PDK2LMNAPTPN1MEN1KMT2A
SCHEMBL20249884 0.86 PDK2 (0.37) PDK2LMNAMEN1KMT2AKDM4E
SCHEMBL20249877 0.84 PDK2 (0.38) PDK2LMNAPTPN1MEN1KMT2A
SCHEMBL14867552 0.83 LMNA (0.42) LMNAMEN1KMT2AKDM4EMAPT
SCHEMBL27865439 0.81 LMNA (0.35) LMNAMEN1KMT2AKDM4EMAPT
SCHEMBL20256949 0.80 KCNA5 (0.41) PDK2LMNAMEN1KMT2AKDM4E
SCHEMBL19759915 0.79 LMNA (0.38) PDK2LMNAMEN1KMT2AKDM4E
SCHEMBL17523190 0.79 LMNA (0.39) LMNAMEN1KMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180166639-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-14 US disclosed
US-20180166639-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180166639-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME RCC1, CCNA1, CTCF PDK2 2677/4885LMNA 1158/4885PTPN1 3484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.